Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.

2.

Nodal Response After Chemo Helps Tailor Breast Radiotherapy

3.

For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.

4.

In Relapsed/Refractory Myeloma, Blenrep-Based Regimen Produces PFS Advantage.

5.

Common intracellular toxin could help fight leukemia


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot